［1］Agusti A, MacNee W, Donaldson K, et al. Hypothesis: does COPD have an autoimmune component?\[J\]. Thorax, 2003,58(10):832-834.［2］Hodson ME, TurnerWarwick M. Autoantibodies in patients with chronic bronchitis\[J\]. Br J Dis Chest, 1976, 70（2）:83-88.［3］中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2007年修订版）\[J\].中华结核和呼吸杂志,2007,30(1)：8-17.［4］ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six minute walk test\[J\]. Am J Respir Crit Care Med, 2002, 166(1): 111-117.［5］Vestbo J,Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary\[J\]. Am J Respir Crit Care Med, 2013,187(4):347-365.［6］Celli BR, Cote CG, Marin JM, et al. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease\[J\]. N Engl J Med,2004, 350(10): 1005-1012.［7］Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases\[J\].Am J Clin Pathol,2002,117(2): 316-324.［8］Daffa NI, Tighe PJ, Corne JM, et al. Natural and diseasespecific autoantibodies in chronic obstructive pulmonary disease\[J\]. Clin Exp Immunol, 2015, 180(1): 155-163.［9］Peng YC, Hsieh SC, Yang DY, et al. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection\[J\]. J Clin Gastroenterol, 2001, 33(5): 402-406.［10］MedinasAmors M, Alorda C, Renom F, et al. Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity of the BODE index\[J\]. Chron Respir Dis,2008,5(1):7-11.［11］Plintoplata VM, Cote C,Cabral H, et al. The 6min walk distance: change over time and value as a predictor of survival in severe COPD\[J\]. Eur Respir J,2004,23(1): 28-33.
2017, Vol. 27 
